CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

The Annexure

Desk› Healthcare› Ishita Drugs & Industries Ltd

Ishita Drugs & Industries Ltd

BSE 524400 ISHITADR INE806D01016
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

4 filings · 0 material · busiest 2026-06-19 and 2026-06-24

What it files

General2 Board Meeting1 Compliance Certificate1

Filings

4 in the window

  1. 31 July 2026

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations, 2015 For The Quarter Ended 30Th June, 2026.

    Ishita Drugs & Industries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to consider and approve 1. To consider, approve ....

    Board Meeting / Board Meeting View filing →

  2. 9 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliance Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2026 as attached.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  3. 24 June 2026

    General

    Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

    Disclosure under regulation 29(2) of SEBI(SAST) Regulations, 2011, received from Ishita Pharmaceuticals, related party of Ishita Drugs and Industries Limited.

    Company Update / General View filing →

  4. 19 June 2026

    General

    Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

    Disclosure under regulation 29(2) of SEBI (SAST) Regulations, 2011, received from Ishita Pharmaceuticals, related party of ishita Drugs and Industries Limited.

    Company Update / General View filing →